12.85
price down icon10.89%   -1.57
after-market Handel nachbörslich: 12.30 -0.55 -4.28%
loading

Capsovision Inc Aktie (CV) Neueste Nachrichten

pulisher
Dec 11, 2025

CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech

Dec 11, 2025
pulisher
Dec 11, 2025

Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Dec 11, 2025
pulisher
Dec 11, 2025

Is CapsoVision Showing How Far A Single Capsule Can Take A Med-Tech Company? - RTTNews

Dec 11, 2025
pulisher
Dec 10, 2025

What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Benzinga

Dec 10, 2025
pulisher
Dec 10, 2025

A look into CapsoVision Inc (CV)’s deeper side - setenews.com

Dec 10, 2025
pulisher
Dec 08, 2025

CapsoVision Welcomes David Garcia to its Senior Executive Team - Medical Product Outsourcing

Dec 08, 2025
pulisher
Dec 05, 2025

CapsoVision (CV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 05, 2025
pulisher
Nov 30, 2025

CapsoVision reports Q3 EPS (17c) vs ($2.79) last year - MSN

Nov 30, 2025
pulisher
Nov 20, 2025

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference - GlobeNewswire

Nov 20, 2025
pulisher
Nov 20, 2025

CapsoVision (NASDAQ: CV) to Host 1:1 Investor Meetings at Benchmark Discovery Conference - Stock Titan

Nov 20, 2025
pulisher
Nov 18, 2025

CapsoVision, Inc.Common Stock (NQ: CV - FinancialContent

Nov 18, 2025
pulisher
Nov 18, 2025

FY2028 EPS Estimates for CapsoVision Cut by Roth Capital - MarketBeat

Nov 18, 2025
pulisher
Nov 16, 2025

CapsoVision (CV) Price Target Increased by 20.00% to 6.12 - Nasdaq

Nov 16, 2025
pulisher
Nov 16, 2025

CapsoVision CFO Kevin Lundquist Steps Down - MSN

Nov 16, 2025
pulisher
Nov 15, 2025

David Michael Garcia Net Worth (2025) - GuruFocus

Nov 15, 2025
pulisher
Nov 15, 2025

Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 By Investing.com - Investing.com Australia

Nov 15, 2025
pulisher
Nov 14, 2025

Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 - Investing.com

Nov 14, 2025
pulisher
Nov 13, 2025

CapsoVision Reports Revenue Growth and Strategic Advances - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

CapsoVision Q3 2025 Earnings Call Transcript - MarketBeat

Nov 13, 2025
pulisher
Nov 13, 2025

CapsoVision, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 13, 2025
pulisher
Nov 13, 2025

CapsoVision, Inc. (CV) Q3 FY2025 earnings call transcript - Yahoo Finance

Nov 13, 2025
pulisher
Nov 13, 2025

[8-K] CapsoVision, Inc Reports Material Event | CV SEC FilingForm 8-K - Stock Titan

Nov 13, 2025
pulisher
Nov 13, 2025

CapsoVision Reports Third Quarter 2025 Financial Results - GlobeNewswire

Nov 13, 2025
pulisher
Nov 12, 2025

CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Ex - GuruFocus

Nov 12, 2025
pulisher
Nov 12, 2025

CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Nov 12, 2025
pulisher
Nov 11, 2025

CapsoVision CFO Lundquist steps down - MSN

Nov 11, 2025
pulisher
Nov 11, 2025

CapsoVision Seeks FDA Breakthrough Status for CapsoCam - MSN

Nov 11, 2025
pulisher
Nov 11, 2025

CapsoVision seeks FDA breakthrough status for pancreatic cancer tool By Investing.com - Investing.com Nigeria

Nov 11, 2025
pulisher
Nov 10, 2025

CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule - The Manila Times

Nov 10, 2025
pulisher
Nov 10, 2025

CapsoVision seeks FDA breakthrough status for pancreatic cancer tool - Investing.com

Nov 10, 2025
pulisher
Nov 07, 2025

Q3 Earnings Forecast for CapsoVision Issued By Roth Capital - MarketBeat

Nov 07, 2025
pulisher
Nov 06, 2025

CapsoVision (NASDAQ:CV) and Bioventus (NASDAQ:BVS) Financial Contrast - Defense World

Nov 06, 2025
pulisher
Nov 06, 2025

Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy - Defense World

Nov 06, 2025
pulisher
Nov 05, 2025

United States Smart Pills Market to hit US$ 619.10 Million by 2033 - openPR.com

Nov 05, 2025
pulisher
Nov 04, 2025

CapsoVision appoints David Garcia as SVP of finance By Investing.com - Investing.com Australia

Nov 04, 2025
pulisher
Nov 03, 2025

[Form 3] CapsoVision, Inc Initial Statement of Beneficial Ownership - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Capsovision, Inc. Appoints David Garcia as Senior Vice President of Finance and Principal Accounting Officer, Effective November 3, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision Appoints David Garcia as Finance VP - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision appoints David Garcia as SVP of finance - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision Appoints David Garcia as Senior Vice President of Finance - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision Appoints New Principal Financial Officer - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision, Inc. Appoints David Garcia as Principal Financial Officer, Effective from November 3, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

CapsoVision (NASDAQ: CV) names David Garcia SVP of Finance; ex-Matterport FP&A VP - Stock Titan

Nov 03, 2025
pulisher
Oct 30, 2025

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 28, 2025

CapsoVision (NASDAQ:CV) & Bioventus (NASDAQ:BVS) Critical Review - Defense World

Oct 28, 2025
pulisher
Oct 25, 2025

Weiss Ratings Reaffirms "Sell (E-)" Rating for CapsoVision (NASDAQ:CV) - MarketBeat

Oct 25, 2025
$295.70
price up icon 0.52%
medical_devices STE
$251.79
price down icon 0.28%
medical_devices PHG
$26.62
price down icon 1.44%
$66.96
price down icon 2.87%
$83.96
price down icon 2.43%
medical_devices EW
$83.08
price down icon 1.38%
Kapitalisierung:     |  Volumen (24h):